936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Case studies of sarcoma and MRCLS following treatment with NY-ESO-1 TCR T Cells (GSK3377794): Correlates of predictable response characteristics
    Meeting Abstract

    Van Tine, B.; D'Angelo, S.; Gyurdieva, A.; Johnson, L.; Turner, D.; Tress, J.; DeYoung, M. P.; Wu, Y.; Hasan, A.; Araujo, D.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: Primary analysis after ≥ 15 months of follow-up from JAVELIN Merkel 200, a registrational phase 2 trial
    Meeting Abstract

    D'Angelo, S.; Lebbé, C.; Mortier, L.; Brohl, A.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G.; Hassel, J.; Kiecker, F.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1 trial of NY-ESO-1-specific adoptive T-cell therapy with GSK3377794 in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Tress, J.; DeYoung, M. P.; Hasan, A.; Wu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design
    Meeting Abstract

    D'Angelo, S.; Blay, J. Y.; Chow, W.; Demetri, G.; Thistlethwaite, F.; Wagner, M.; Loeb, D.; Attia, S.; Razak, A.; Haanen, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • INVICTUS: A phase III, interventional, double-blind, placebo-controlled study to assess the safety and efficacy of ripretinib as ≥ 4th-line therapy in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior anticancer therapies (NCT03353753)
    Meeting Abstract

    von Mehren, M.; Serrano, C.; Bauer, S.; Gelderblom, H.; George, S.; Heinrich, M.; Schöffski, P.; Zalcberg, J.; Chi, P.; Jones, R. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of cardiotoxicity (CT) associated with doxorubicin (dox) in patients (pts) with advanced soft tissue sarcoma (STS) in a phase III randomized trial
    Meeting Abstract

    Jones, R. L.; Wagner, A.; Kawai, A.; Shahir, A.; Soldatenkova, V.; Wright, J.; Tap, W. D.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
    Meeting Abstract

    Gounder, M. M.; Merriam, P.; Ratan, R.; Patel, S. R.; Chugh, R.; Villalobos, V.; Thorton, M.; Van Tine, B. A.; Abdelhamid, A. H.; Joshi, P.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with metastatic Merkel cell carcinoma receiving second-line or later avelumab treatment: 36-month follow-up data
    Meeting Abstract

    D'Angelo, S. P.; Nolte, S.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • METEOR-1: A phase I study GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
    Meeting Abstract

    Siu, L. L.; Rasco, D. W.; Postel Vinay, S.; Martin Romano, P.; Menis, J.; Opdam, F. L.; Heinhuis, K. M.; Egger, J. L.; Gorman, S. A.; Parasrampuria, R.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)
    Meeting Abstract

    Bauer, S.; Lewis, J. H.; Gelderblom, H.; van de Sande, M.; Stacchiotti, S.; Healey, J. H.; Tap, W. D.; Wagner, A. J.; Pousa, A. L.; Druta, M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save